Sam was a graduate student in the lab of bioengineering professor Hao Yuan Kueh where he studied the control processes underlying T-cell development. These fundamental mechanisms could be used in the future to engineer immune cells to fight against various types of cancer. He also built artificial intelligent systems that extract insights from movies of live cell interaction to advance the field of image analysis. Sam is currently pursuing a postdoc in California. Read More
As a graduate student in the lab of bioengineering professor Buddy Ratner, Runbang developed molecularly imprinted polymers and membranes that are able to specifically remove uremic toxins with enough capacities for portable kidney dialysate devices. He holds a B.S. in Materials Science and Engineering from Harbin Institute of Technology (China) and an M.S. in Materials Science and Engineering from Cornell. Read More
Ruihong “Redd” Wang was co-advised by bioengineering professor Michael Jensen and genome sciences professor John Stamatoyannopoulos. Redd developed a new platform for high-throughput functional genotyping of regulatory elements at the single cell level. He is currently a research scientist at the Altius Institute for Biomedical Sciences. Read More
Dr. Gamble's research focuses on surface modification and characterization of model biomedical systems including fundamental research towards the preparation and characterization of DNA and protein microarrays. She is also involved in the development of new techniques that will enable improved analysis of the biomolecule-surface interface and improved chemical imaging of biologically relevant samples. Read More
Our group designs and develops functional materials and structures on the nanometer scale. Examples include multicolor quantum dots for fluorescence imaging, magnetic nanoparticles for MRI, metallic nanoparticles for ultrasensitive detection, and polymeric nanoparticles for targeted drug delivery. Most recently, we are developing multimodality imaging probes by combining different materials into discrete nanostructures in order to utilize the strength of each individual component. Read More
Our lab studies how immune cells make fate decisions, both as they develop from stem cells, and as they respond to antigens. We combine live cell imaging, mathematical modeling and other modern approaches to dissect the molecular circuitry underlying fate control at the single cell level. Our work will lay foundations for engineering immune cells to treat cancer and other life-threatening diseases. Read More
Research in the Pun Group focuses on advancing macromolecule drug delivery technology by developing materials that overcome transport limitations in tissues and within cells. We are integrating techniques from engineering, chemistry, and cell biology to achieve this goal. Read More
Medical devices and implants are engineered from specially designed materials, often referred to as biomaterials. Millions of devices and implants are used clinically in applications as diverse as blood vessel replacements, catheters, contact lenses, hip joints, ventricular assist devices and artificial kidneys. The biocompatibility of these prostheses is dictated by their surface properties and by the local mechanical environment they induce. In my research program, biomaterials are engineered to control biological interactions, synthesized, characterized and observed during interaction with biological systems. Read More
Our group is interested in elucidating the fundamental mechanisms of biomolecular recognition and applying the unique capabilities of biological molecules to biotechnologies. We would like to bridge the gap between understanding molecular structure-function relationships, and to be able to utilize proteins/peptides/DNA for in vivo drug therapies, bioseparations, diagnostics, and biomaterial development. Read More
The Woodrow Laboratory is focused on the applications of engineered biomaterials in mucosal infections and mucosal immunity. Our long-term goals are to design and build multifunctional materials that will: (1) lead to novel preventative strategies against mucosal infections, (2) program protective immune responses at mucosal sites of pathogen entry, and (3) facilitate studies of mucosal infections and mucosal immunity in health and disease. These scientific goals are addressed from the perspective of fundamental science, technology development, and translational research. Read More